Dr. Khalil Sultanem, MD
Claim this profileJewish General Hospital
Studies Neck Cancer
Studies Oropharyngeal Cancer
6 reported clinical trials
15 drugs studied
Area of expertise
1Neck Cancer
Stage I
Stage II
p16 positive
2Oropharyngeal Cancer
Stage I
Stage II
p16 positive
Affiliated Hospitals
Clinical Trials Khalil Sultanem, MD is currently running
SABR Boost + Short-course Radiation
for Oropharyngeal Cancer
This is a randomized clinical trial comparing the outcomes of short-course chemoradiation consisting in stereotactic boost to the gross tumor and de-esclalated chemoradiation to the elective neck in human papilloma associated oropharynx cancer vs. the current standard 7-week course chemoradiation.
Recruiting2 awards Phase 39 criteria
NBTXR3 +/− Cetuximab
for Head and Neck Cancer
This is a global, open-label, randomized, 2-arm, Investigator's choice Phase 3 (Pivotal Stage) study to investigate the efficacy and safety of JNJ-90301900 (NBTXR3) / radiation therapy (RT)±cetuximab versus RT±cetuximab in treatment-naïve, platinum-ineligible, elderly participants with locally advanced head and neck squamous cell carcinoma (LA-HNSCC).
Recruiting2 awards Phase 319 criteria
More about Khalil Sultanem, MD
Clinical Trial Related7 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Khalil Sultanem, MD has experience with
- Cisplatin
- Radiation
- SABR Boost And De-escalated Chemoradiation
- Standard Chemoradiation
- Fluorouracil
- Gemcitabine Hydrochloride
Breakdown of trials Khalil Sultanem, MD has run
Neck Cancer
Oropharyngeal Cancer
Head and Neck Cancers
Squamous Cell Carcinoma
Human Papillomavirus
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Khalil Sultanem, MD specialize in?
Khalil Sultanem, MD focuses on Neck Cancer and Oropharyngeal Cancer. In particular, much of their work with Neck Cancer has involved Stage I patients, or patients who are Stage II.
Is Khalil Sultanem, MD currently recruiting for clinical trials?
Yes, Khalil Sultanem, MD is currently recruiting for 2 clinical trials in Montreal Quebec. If you're interested in participating, you should apply.
Are there any treatments that Khalil Sultanem, MD has studied deeply?
Yes, Khalil Sultanem, MD has studied treatments such as Cisplatin, Radiation, SABR boost and de-escalated chemoradiation.
What is the best way to schedule an appointment with Khalil Sultanem, MD?
Apply for one of the trials that Khalil Sultanem, MD is conducting.
What is the office address of Khalil Sultanem, MD?
The office of Khalil Sultanem, MD is located at: Jewish General Hospital, Montreal, Quebec H3T 1E2 Canada. This is the address for their practice at the Jewish General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.